The above results reveal that down-regulation of miR-21 with antagmir-21 inhibits angiogenesis in breast tumor via targeting HIF-1α/VEGF/VEGFR2-associated signaling pathway. The gene discussed is HIF1A; the disease is breast neoplasm.